BamSEC and AlphaSense Join Forces
Learn More

Royalty Pharma plc – Indentures

NASDAQ: RPRX    
Share price (6/22/26): $53.57    
Market cap (6/22/26): $30.8 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 40 pages Fifth Supplemental Indenture Dated as of September 16, 2025 Supplementing That Certain Indenture Dated as of September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd, Royalty Pharma Manager, LLC and Wilmington Trust, National Association, as Trustee 4.450% Senior Notes Due 2031 5.200% Senior Notes Due 2035 5.950% Senior Notes Due 2055
12/34/56
EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 40 pages Third Supplemental Indenture Dated as of June 10, 2024 Supplementing That Certain Indenture Dated as of September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd and Wilmington Trust, National Association, as Trustee 5.150% Senior Notes Due 2029 5.400% Senior Notes Due 2034 5.900% Senior Notes Due 2054
12/34/56
EX-4.4
from S-3ASR 74 pages Subordinated Indenture Dated as of , 20 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd and Wilmington Trust, National Association, as Trustee
12/34/56
EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 40 pages Second Supplemental Indenture Dated as of July 26, 2021 Supplementing That Certain Indenture Dated as of September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee 2.150% Senior Notes Due 2031 3.350% Senior Notes Due 2051
12/34/56
EX-4.4
from S-3ASR 74 pages Subordinated Indenture Dated as of , 20 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee
12/34/56
EX-4.2
from 10-K 6 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56
EX-4.1
from DRS 2 pages Pursuant to 17 C.F.R. Section 200.83
12/34/56
EX-4.9
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 53 pages First Supplemental Indenture Dated as of September 2, 2020 Supplementing That Certain Indenture Dated as of September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee 0.750% Senior Notes Due 2023 1.200% Senior Notes Due 2025 1.750% Senior Notes Due 2027 2.200% Senior Notes Due 2030 3.300% Senior Notes Due 2040 3.550% Senior Notes Due 2050
12/34/56
EX-4.1
from 8-K 69 pages Indenture Dated as of September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56